-Advertisement-
-Advertisement-
FDA Alerts
Lupus Nephritis
Trending Topics
FDA approves Saphnelo for moderate to severe systemic lupus erythematosus
Early hospital readmission increases mortality in patients with ILD
Grants awarded to young scientists supporting next generation of lupus researchers
Significant health toll felt by patients with systemic lupus erythematosus during COVID-19
Renewed focus needed for treatment of some adolescent cancers
-Advertisement-
Alagille Syndrome
July 21, 2021

The U.S. Food and Drug Administration has approved odevixibat (Bylvay; Albireo Pharma, Inc) for the treatment of pruritus in all subtypes of progressive familial intrahepatic cholestasis (PFIC), according to a press release. Odevixibat...

-Advertisement-
-Advertisement-
-Advertisement-
Lupus Nephritis
August 3, 2021

The U.S. Food and Drug Administration has approved anifrolumab-fnia (Saphnelo; AstraZeneca), a first-in-class type I interferon receptor antagonist for adults with moderate to severe systemic lupus erythematosus (SLE), according to a press release....

-Advertisement-
-Advertisement-
-Advertisement-
Sarcoma
July 28, 2021

Although progress in survival trends for brain cancer, lung cancer, acute myeloid leukemia, and colon and rectum cancers in adolescents has been made over the last 40 years, new research shows that minimal...

-Advertisement-
-Advertisement-
-Advertisement-

Polls

Poll: How often do you encounter Alagille syndrome?
Jul 20, 2021

Podcasts

Rare Disease Drug Shortage During COVID-19 Effort Creates Dilemma
Feb 15, 2021

Quizzes

Case Study Quiz: Lupus Nephritis Class III & Pregnancy
Jun 22, 2021

Videos

ASCO – Retroperitoneal Sarcomas: the Benefits of Radiotherapy
May 27, 2021
Thyroid Eye Disease
June 7, 2021

Mycophenolate mofetil (MMF) appears safe and effective as a second-line immunosuppressive agent in patients with thyroid eye disease (TED), according to a study. In this retrospective cohort study, 20 patients with active moderate-severe to sight-threatening...

-Advertisement-
-Advertisement-
-Advertisement-
Interstitial Lung Disease
August 2, 2021

Preventing early hospital readmission in patients with interstitial lung disease (ILD) may impact clinical course in these patients, according to a study that found that early readmission increased short-term and long-term mortality. In...

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-